InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the detailed record of transactions filed by Miller James Charles, 董事. Director active across 2 companies, notably Recro Pharma, Inc.. In total, 6 disclosures have been recorded. Split: 3 buys · 0 sell. Total volume traded: €17k. History available since 17 November 2021. The latest transaction was disclosed on 8 April 2024 (U). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Miller James Charles is Administrateur at Societal CDMO, Inc. and Recro Pharma, Inc. He has 6 filings in total, and among the recent filings available, they cover the period from 2021-11-19 to 2024-04-08, with purchases totaling EUR 17280 and no sales; the modal transaction nature is Acquisition.